NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
Funding Amount
Not stated
Deadline
July 5, 2029
960 days left
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Tribal governments
- County governments
- Nonprofits (501(c)(3))
- Tribal organizations
- Private colleges & universities
- Public colleges & universities
- State governments
- School districts
Overview
NIAID Clinical Trial Implementation Cooperative Agreement
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the NIAID Clinical Trial Implementation Cooperative Agreements. This program encourages cooperative agreement applications for implementation of investigator-initiated, milestone driven, high-risk clinical trials including mechanistic studies associated with these clinical trials. Due to this focus, the program encompasses both basic and clinical research. This program includes support for the conduct, completion, and analysis of the clinical trial. Additional activities supported are related to the conduct of the clinical trial including training of study personnel; enrollment and recruitment of study subjects; data collection, clinical data management and quality control; investigational product costs; laboratory work and data analyses; study management and oversight; post-trial activities; and regulatory activities and site monitoring. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: FOR-AI-27-007
- Instrument: cooperative_agreement
Focus Areas & Funding Uses
Fields of Work
- Science research
- Healthcare
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
November 19, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
National Institutes of Health
Amount
Varies
Deadline
November 19, 2026
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $375,000
Deadline
November 23, 2026
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$3,400,000 total
Deadline
November 23, 2026
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$6,000,000 total
Deadline
November 23, 2026
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$3,500,000 total
Deadline
November 23, 2026
Ready to apply for NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required). Now let's win it.